Inheritance of the Ity' or the ItyS allele of the Ity murine gene confers resistance or increased susceptibility, respectively, to SalmoneUla typhimurium infection. Recent studies have documented that Ity gene expression may determine net intracellular replication of S. typhimurium by modulating macrophage function. The purpose of this study was to determine if Ity gene expression modulated macrophage stem cell proliferation as well. To detect possible Ity-associated alterations in macrophage stem cell proliferation during endotoxin challenge or S. typhimurium infection, the congenic strain pair BALB/c (ItS) and C.D2-Idh-1, Pep-3 N20F8 (Ityr) were injected intraperitoneally with 25 ,ug of bacterial lipopolysaccharide (LPS) or -103 S. typhimurium, and myelopoiesis was evaluated. At 72 h after LPS injection, both BALB/c and C.D2 mice developed comparable degrees of bone marrow hypocellularity and splenomegaly, and cell sizing profiles indicated a normal response to a single injection of LPS in both strains of mice. Although an inhibitor to colony-stimulating factor activity was detected in the sera and plasma of C.D2 mice, the number of myeloid stem cells cultured from the bone marrow and spleen of each mouse strain were comparable. S. typhimurium infection resulted in earlier symptoms, a larger bacterial load, a higher mortality rate, and a greater bone marrow hypocellularity and splenomegaly in BALB/c mice compared with those in C.D2 mice. Despite a dramatic increase in bacterial load, a decrease in both bone marrow and splenic myeloid stem cell numbers was noted in BALB/c mice, while stem cell numbers remained constant in C.D2 mice between days 3 and 5 and increased dramatically at day 7 after infection. These data suggest that BALB/c and C.D2 mice may exhibit a divergent myelopoietic response to S. typhimurium infection. It appears that a paradoxical failure of myelopoiesis in ItyS mice during S. typhimurium infection may contribute to the observed increase in mortality.
In mice, the ability of the macrophage to contain early intracellular proliferation and subsequent dissemination of Salmonella typhimurium plays a pivotal role in host defense against this organism (3, 4, 17, 22, 33, 44, 47 ). An effective macrophage response to such infections is both quantitative (expansion of the macrophage pool) and qualitative (acquisition of an appropriate repertoire of antimicrobial functions). The observation that different inbred strains of mice exhibit variable degrees of susceptibility to S. typhimurium, as well as to Leishmania donovani and Mycobacterium bovis, has led to the discovery of a gene(s) that appears to modulate host defense to these infections (3, 25, 30, 32, 34-36, 41, 43, 48) . One such gene, designated Ity (immunity to typhimurium), can, depending on the allele inherited, confer either increased resistance (Ityr) or increased susceptibility (Itys) to infection with S. typhimurium (30, 32, 36, 41) . The gene(s) controlling murine susceptibility to L. donovani and M. bovis are designated Lsh and Bcg, respectively (3, 12, 18, 35, 41) . A growing body of evidence suggests that Ity, Lsh, and Bcg are identical, as they are all located on chromosome 1 within 2 centimorgans of the gene which encodes the cytoskeleton-associated protein, villin (25, 35) . BcgILshIIty-mediated immunoincompetence (3, 12, 16, 18, 31, 47, 48) . Transplantation of Ity1 bone marrow cells into irradiated Ity's mice confers resistance to S. typhimurium (5, 16) , while treatment of Ity1 mice with silica eliminates resistance (33) . In vitro comparisons of macrophages from ftyr and Ify5 mice demonstrate that macrophages from Ityr mice have superior superoxide anion-generating capacity and tumoricidal activity (7) . Macrophages, taken from Ityr mice infected with bacillus Calmette-Guerin (M. bovis BCG) or after in vitro exposure to high-dose gamma interferon (IFN-y), exhibit expression of I-A antigen for prolonged periods (12, 18, 48) .
Although functional differences between Ityr and Ify5 macrophages are well documented, very little is known about the quantitative aspects of the macrophage response to S. typhimurium. An appropriate response requires rapid expansion of the macrophage stem cell pool, movement of stem cells into the monocyte-macrophage differentiation pathway, and maturation and activation of the end-stage effector cell. A failure of macrophage stem cell proliferation and/or an inadequate production of the colony-stimulating factor(s) (CSFs) that modulates stem cell proliferation could have serious consequences for host immunity to S. typhimurium infection (27, 44) . Measurements of serum CSF activity and bone marrow myeloid stem cell proliferation following S. typhimurium infection have been reported only once in a mouse model, and the mouse strain was relatively resistant to infection with S. typhimurium (44) .
In this study, we investigated the possibility that defects in the regulation of macrophage stem proliferation and/or CSF production may, in addition to the observed macrophage functional defects, play a role in the increased susceptibility of Itys mice to infections with S. typhimurium. The congenic strain pair BALB/c (Itys) and C.D2-Idh-1, Pep-3 N20F8 (Ityr) mice, the latter referred to hereafter as C.D2 mice, were utilized in our studies. These two mouse strains are genetically identical except for a 30-centimorgan segment of DNA (contained in the DBA/2 portion of the C.D2 genome) which expresses the Ity allele (30, 36) . BALB Detection of S. typhimurium in bone marrow, spleen, and blood. Monodispersed tibial bone marrow and spleen cells were diluted serially in sterile, pyrogen-free water, and triplicate 10-pl samples were promptly cultured overnight on tryptic soy agar at 37°C. The number of viable bacteria in a given organ was calculated from the plate counts and the dilution of the inoculum and is expressed as the number of bacteria per organ. Blood cultures were performed by inoculating 100 ,ul of heparinized whole venous blood into 5 ml of Antibiotic Medium 3 (Difco) and incubating for 48 h at 37°C. CSF bioassays. Serum and plasma were assayed for CSF activity by using a previously described technique (15 (15) . Plasma, serum, and tissue collection. Anesthetized (methoxyflurane; Pitman-Moore, Inc., Washington Crossing, N.J.) mice were exsanguinated through a midline incision via the inferior vena cava, and aliquots of heparinized blood were analyzed for total leukocyte (WBC) counts and bacterial growth prior to harvesting and freezing of unpooled plasma samples. In a separate experiment, pooled serum samples were obtained from the retro-orbital sinus. Spleens were excised; placed in antibiotic-free RPMI 1640 tissue culture medium (MA Bioproducts, Walkersville, Md.) supplemented with 2 mM glutamine, 30 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and 3 mg of sodium bicarbonate per ml; and gently passed through sterile wire mesh screens. Bone marrow cells were flushed from both tibias with antibiotic-free, supplemented RPMI 1640 by using a 1-ml syringe with a 25-gauge needle. Monodispersed bone marrow and spleen cells, 100 ,ul per sample, were serially diluted in sterile water and plated on tryptic soy agar to quantitate bacterial growth. The remaining cells were washed and resuspended in supplemented RPMI 1640 containing an antibiotic-antimycotic (penicillin G, 10,000 U/ml; streptomycin sulfate, 10,000 pg/ml; and amphotericin B, 25 ,ug/ml [GIBCO Laboratories, Grand Island, N.Y.]) and 10% heat-inactivated fetal bovine serum (Hyclone, Logan, Utah) and maintained on ice until cell counts, cell sizing profiles, and hematopoietic stem cell cultures could be accomplished.
Cell counts and sizing profiles. Bone marrow and spleen nucleated cell counts were performed and histograms of bone marrow and spleen cells were generated on a Coulter Counter ZM and Coulter Channelyzer 100 equipped with a X-Y Recorder 4 (Coulter Electronics, Inc., Hialeah, Fla.) as previously described (9) . The distribution of cell size was based on 104 observations per sample, and the number of cells falling within a given size range was determined by integrating the area under the curve for each histogram.
Quantitation of granulocyte and macrophage progenitors.
The number of CFU-macrophages (CFU-M) and CFU-GM per organ that were generated from unseparated tibial bone marrow and spleen were determined in soft agar cultures as previously described (23) . Briefly, 1 x 105 bone marrow or 2.5 x 106 spleen cells were cultured in 2 ml of 0.33% agar-medium mixture layered over 2-ml feeder layers containing 0.66% agar medium with 5 x 104 U of either rhCSF-1 or rmuGM-CSF. Cultures RESULTS Myelopoietic response to LPS. To explore the possibility that myelopoietic responsiveness to LPS may be expressed differently in Ity' and Ityr mice, the effects of an LPS injection on myelopoiesis were investigated in BALB/c (Itys) and C.D2 (Ityr) mice by quantitating the nucleated cellularity of bone marrow and spleen taken 72 h after a single 25-,ug i.p. injection of LPS. Compared with saline-injected controls, BALB/c and C.D2 mice responded to LPS injection with comparable degrees of bone marrow hypocellularity and splenomegaly. Tibial bone marrow cellularity, expressed as the arithmetic mean + standard error of the mean (SEM) of four separate experiments, was 7.3 x 106 ± 0.6 x 106 nucleated cells for BALB/c mice and 8.0 x 106 ± 2.0 x 106 nucleated cells for C.D2 mice. Corresponding nucleated spleen cell counts were 97.6 x 106 + 4.1 x 106 and 91.4 x 106 ± 11.9 x 106 cells per spleen for BALB/c and C.D2 mice, respectively. The differences in bone marrow and splenic cellularity between BALB/c and C.D2 mice 72 h after LPS were not statistically significant.
The myeloid stem cell proliferative response to LPS also failed to reveal statistically significant differences between BALB/c and C.D2 mice. In Table 1 , both the absolute number of progenitor cells (i.e., the colony counts adjusted for organ cellularity) and the actual colony counts per culture (i.e., shown in parentheses and representing a measure of progenitor cloning frequency, based on 105 input cells) are reported. In the bone marrow, LPS-treated mice produced no statistically significant alterations in the absolute number of rhCSF-1-induced (CFU-M) or rmuGM-CSFinduced (CFU-GM) stem cell colonies compared with salineinjected controls. However, the frequency of bone marrow CFU-M in BALB/c mice was statistically increased (P = 0.0035). Although bone marrow stem cell production was comparable for the two mouse strains stimulated with the same CSF, bone marrow cells from either strain cultured in the presence of rhCSF-1 produced approximately three to four times as many CFU-M colonies as bone marrow cells cultured in the presence of rmuGM-CSF, regardless of the treatment (LPS versus saline) employed.
In the spleen, LPS administration resulted in a dramatic expansion of both the CFU-M and CFU-GM stem cell pools (Table 1) . Compared with saline controls, LPS treatment was associated with approximately a 10-fold increase in the absolute number and frequency of splenic CFU-M and CFU-GM in both BALB/c and C.D2 mice. As in the bone marrow, total numbers of CFU-M predominated over CFU-GM in both strains of mice, although the ratio of CFU-M to CFU-GM was somewhat higher in bone marrows than spleens, regardless of treatment.
We have shown previously that dramatic alterations in nucleated bone marrow cell sizing profiles occur 72 h after LPS administration in C3H/OuJ mice, a Lps' strain that is normally responsive to LPS (23) . These data indicate that the vast majority of cells in the bone marrow of normal C3H/OuJ mice are found in two peaks of a cell sizing histogram. In saline-injected mice, peak I accounts for 35 to 40% of the total number of cells and consists of a population of smaller cells (mean diameter, 7.5 ,um). Peak II consists of relatively larger cells (mean diameter, 10.0 ,um) that represent 60 to 65% of the cell population. After LPS injection, the percentage of cells in peak I falls dramatically (to -20% of the total number of cells) and there is a compensatory increase in the size (mean diameter, 11.4 ,um) and relative number (-80% of the total) of bone marrow cells in peak II. As another means of investigating the myelopoietic response to LPS in Ity' and Ityr mice, we compared bone marrow cell sizing histograms in BALB/c and C.D2 mice 72 h after LPS injection. No statistically significant differences in cell sizing profiles between the two strains were found, and shifts in the bimodal distribution of cells following LPS injection mirrored alterations found previously in C3H/OuJ mice, suggesting that both BALB/c and C.D2 mice responded normally to LPS (15, 23) .
The effect of LPS on blood levels of CSF activity was also monitored in an attempt to discriminate between the myelopoietic responses of BALB/c and C.D2 mice following LPS treatment. Six hours after a 25-p,g i.p. injection of LPS, retro-orbital sinus blood was collected, and pooled serum samples were assayed for CSF activity at final serum concentrations of 1.25, 2.5, and 5% ( Fig. 1) . At a concentration of 1.25%, sera from BALB/c and C.D2 mice expressed equivalent CSF activities, but as concentrations of serum were increased to 5% in the bioassay, CSF activity rose in the serum of BALB/c mice and declined in the serum of (5, 13, 27) . Bioassays for these cytokines were performed on serum (IFNs) or plasma (TGF-i1) obtained from BALB/c and C.D2 mice 6 h after receiving LPS (data not shown). Levels of IFNs and TGF-pl were comparable in BALB/c and C.D2 mice, suggesting that neither of these cytokines was responsible for the observed inhibition.
Myelopoietic response to S. typhimurium. Unlike a single, sublethal injection of LPS, it was anticipated that both the magnitude and chronicity of an S. typhimurium infection might expose additional subtle differences in myelopoiesis between Ityr and ItyS mice. To explore this possibility, BALB/c and C.D2 mice received _103 S. typhimurium by i.p. injection. This dose elicits a differential survival response between these two strains within 7 days (43). Indeed, in each of the three experiments, BALB/c mice developed signs of disease (piloerection, conjunctivitis, diarrhea, and lethargy) within 72 h of injection, and all BALB/c mice died within 7 days. C.D2 mice, on the other hand, did not become ill until day 5 after injection and uniformly survived beyond day 7. Positive blood cultures were absent in both mouse strains at day 1 (Table 2 ), but by day 3 after infection, S. typhimurium was recovered from 100% of the blood cultures from BALB/c mice, while only 25% of the blood cultures from C.D2 mice were positive (P = 0.007). S. typhimurium was never recovered from the bone marrow of C.D2 mice but was invariably cultured from bone marrows of BALB/c mice at days 3 and 5 postinjection ( Table 2 ). S. typhimurium did appear in the spleens of C.D2 mice, but compared with BALB/c mice, the time of appearance was delayed (day 5 for C.D2 versus day 3 for BALB/c mice), and the highest bacterial load at day 7 in the C.D2 spleens was 4 logs lower than peak bacterial loads seen at day 5 in BALB/c spleens (P = 0.0286).
Infection had pronounced effects on the nucleated cellularity of bone marrows and spleens in both strains of mice (Fig. 2) , but except for a significantly higher WBC count in normal, uninfected BALB/c mice, WBC were comparable between the two strains and remained in the normal range at days 1, 3, and 5 after infection ( Fig. 2A) . At day 7, the mean WBC in C.D2 mice was significantly increased above normal. Bone marrow cellularity (Fig. 2B) was similar in normal BALB/c and C.D2 mice, but declined precipitously after infection in BALB/c mice while remaining relatively constant in C.D2 mice. As a result, differences in bone marrow cellularity between the two strains at 3 (P = 0.021) and 5 (P = 0.0027) days after infection were statistically significant. Despite significant declines in bone marrow cellularity, compensatory splenomegaly in BALB/c mice was modest and, at day 5, approximated the splenic cellularity observed in C.D2 mice (Fig. 2C) , even though the splenic bacterial load in BALB/c mice was increasing during this period (Table 2 ). In contrast, massive splenomegaly was evident at day 7 in C.D2 mice, and the splenic bacterial load in these mice remained significantly lower and static (Table 2) .
In addition to differences in bone marrow and splenic cellularity for the two strains, infection with S. typhimurium resulted in different temporal patterns of myeloid stem cell proliferation (Fig. 3) . In BALB/c mice, both bone marrow CFU-M and CFU-GM peaked at day 3 before declining significantly (P = 0.0143 and P = 0.014, respectively) at day 5 ( Fig. 3A and B) . In C.D2 mice, bone marrow CFU-M and CFU-GM increased to a lesser extent at day 3, remained (A) WBC: *, P = 0.01; and #, P = 0.018 compared with normal control C.D2 mice. (B) Bone marrow: *, P = 0.019 compared with normal control BALB/c mice and P = 0.021 compared with C.D2 mice at day 3; #, P = 0.0039 compared with normal control BALB/c mice and P = 0.0027 compared with C.D2 mice at day 5. (C) Spleen: *, P = 0.012 compared with C.D2 mice at day 1; #, P < 0.02 compared with respective normal controls; + +, P < 0.01 compared with all other groups of mice.
unchanged at day 5, and rebounded to their highest levels at day 7 after infection. Thus, both the timing and amplitude of changes in bone marrow stem cell numbers differed between the two strains of mice. The remarkable increase in bone marrow and splenic myeloid progenitors in C.D2 mice at day 7 parallels significant increases in WBC and nucleated cells per spleen ( Fig. 2A and C, respectively) that coincide with peak levels in plasma of CSF activity. Together, these data suggest a massive myelopoietic response to S. typhimunum infection at day 7 after infection in C.D2 mice that contrasts sharply with the abortive myelopoietic response observed in BALB/c mice at day 5. The pattern of stem cell proliferation observed in the bone marrows of BALB/c and C.D2 mice was repeated in the spleen (Fig. 3C and D) . Compared with C.D2 mice, splenic macrophage progenitors (CFU-M) in BALB/c mice increased more rapidly and, by day 3, were present in greater numbers (P = 0.014). Again, at day 5, splenic CFU-M declined in BALB/c mice at the same time that bacterial counts were increasing in the spleen. Splenic CFU-M in C.D2 mice remained constant between days 3 and 5. The splenic stem cell CFU-GM response to rmuGM-CSF (Fig.  3D ) recapitulated the CFU-M response described for rhCSF-1, but, as in the bone marrow, CFU-M progenitors outnumbered CFU-GM progenitors. Overall, stem cell proliferation in BALB/c mice was characterized by a rapid, early increase of CFU-M and CFU-GM in the bone marrow and spleen followed by a decrease in the number of myeloid progenitors. Interestingly, this myelopoietic failure manifested itself at the very time an exponential increase in host bacterial load was occurring.
In an attempt to clarify the etiology of this myeloproliferative defect, we measured levels of CSF activity in pooled plasma samples collected serially after infection (Table 3) . Plasma CSF activity was detectable at days 3 and 5 after infection in BALB/c mice but was undetectable in the plasma of C.D2 mice until day 7. Day 7 CSF activity in C.D2 mice was associated with elevated WBC (Fig. 2A) and marked increases in both CFU-M and CFU-GM in bone marrow and spleen (Fig. 3) . Peak plasma levels of CSF activity at day 5 in BALB/c mice coincided with a WBC zenith but did not correlate with peak stem cell proliferation in either the bone marrow or spleen.
In contrast to the failure of a single LPS injection to induce significant differences in bone marrow cell sizing profiles between the two strains, the loss of stem cell proliferative capacity in BALB/c mice at day 5 was accompanied by marked differences in bone marrow cell sizing profiles between the two strains (Fig. 4) . Cell sizing profiles in uninfected BALB/c and C.D2 mice were normal, but as the infection progressed in BALB/c mice, the number of cells found in peak II decreased from 49 to 28%, and the proportion of cells shifting to the right of peak II (Fig. 4 , hatched areas) had increased from 13 to 43%. In contrast, bone marrow cell histograms in C.D2 mice were essentially unchanged through day 5. However, by day 7, the number of cells in peak II had decreased from 57% (normal controls) to 43% with a compensation in larger cells from 11 to 38%. The loss of cells in the second peak of the cell sizing profile of BALB/c mice at day 5 corresponded to the precipitous decline in bone marrow CFU-M and CFU-GM, confirming an absolute decrease in the size of the myeloid stem cell pool.
DISCUSSION
An appropriate phagocytic cell response is critical to survival following infection. During the first 72 h of infection with S. typhimurium, polymorphonuclear neutrophils are the predominant cell type found in microabscesses of the liver and spleen of infected mice, suggesting an important role for polymorphonuclear neutrophils in the early response to infection (46) . However, macrophages have been more directly implicated in the host defense to S. typhimunium. The fact that treatment of normally resistant mice with silica increases their susceptibility to S. typhimurium provides indirect evidence that macrophages are important in host defense to salmonellosis (33) . Moreover, adoptive transfer of immunity to S. typhimurium has been accomplished by injecting splenic macrophages from mice immunized with an avirulent strain of S. typhimurium into syngeneic recipients, providing direct evidence for a role for activated macrophages in acquired resistance to S. typhimurium (19) .
In Itys mice, macrophages fail to express at least two critical functions in response to S. lyphimunium infection.
First, although macrophages from ItyS mice ingest and initially destroy as many organisms as macrophages from Ityr mice, the bacteria that do survive within macrophages are handled differently in the two strains of mice; net intracellular proliferation of S. typhimunum continues in Itys but declines over time in Ity macrophages (20, 43) . This divergent macrophage response to the intracellular growth of S. typhimunum is evident within 24 h of infection (43) and may be related to a defect in a cytochalasin B-sensitive, intracellular bactericidal activity (4) . These data suggest that the Ity allele may be involved in the regulation of macrophage bactericidal activity. An alternative interpretation has been offered by Benjamin et al., who have presented evidence that the Ity gene, in concert with bacterial virulence factors, regulates the net intracellular proliferation of S. typhimunum (2) . In their studies, net bacterial proliferation 6 days after infection was consistently greater in strains of mice bearing the Itsy allele. The bacteriologic surveillance studies in the current investigation are consistent with previous observations that initial macrophage immune responses of both Ityr and Itys mice are intact but that a The lower limit of sensitivity for this bioassay is 20 U/ml, and normal mouse serum from both strains contained <20 U of CSF activity per ml.-, no survivors. subsequent proliferation of the bacteria is favored in Itys macrophages (20, 43) . Bacteriologic cultures of blood, bone marrow, and spleen were negative 1 day after infection in both strains, suggesting effective early containment of bacteria, but by day 3, differences in bacterial load between BALB/c and C.D2 mice were evident in all three tissues (Table 2 ). Similar observations have been made by others (31, 44) .
A second macrophage defect has been described by Zwilling et al. (12, 18, 48) . Peritoneal macrophages from ItyS and Ityr mice exhibit different capacities to express I-A antigen (12, 18, 48) . Twenty-eight days after an i.p. injection of BCG or Corynebacterium parvum, macrophages from Itys mice express I-A antigen only transiently, while macrophages from Ityr mice express I-A continuously for at least 7 days in culture (48) . Addition of pharmacological amounts (100 U/ml) of recombinant IFN--y can also induce continuous in vitro expression of I-A in macrophages from Ityr but not ItyS mice, suggesting that the macrophage defect in ItyS mice may preclude a normal response to IFN--y.
In contrast to the well-documented qualitative defects, very little is known about the quantitative response of Ityr and Itys macrophages to S. typhimurium infection. Macrophage proliferation and differentiation are directly controlled at the cytokine level by two CSFs, GM-CSF and CSF-M or CSF-1. Both CSF-1 and GM-CSF are absolutely essential for the proliferation, differentiation, and survival of cells in the macrophage lineage and regulate effector cell function as well (11, 14, 27, 38) . In vitro, both the proliferative potential of bone marrow stem cells and the functional status of their mature progeny are influenced by the type and amount of CSF to which they are exposed (8-11, 27, 38, 39) . For example, when maximal stimulating doses of GM-CSF or CSF-1 are used to stimulate bone marrow cultures, CSF-1 induces five times as many murine bone marrow stem cell colonies as GM-CSF (9). Proliferation of CFU-M and CFU-GM following LPS in our study was indistinguishable between the two strains, and as noted by others, rhCSF-1 stimulated more stem cell colony growth than rmuGM-CSF (9, 27, 29) . The reason for the superior cloning efficiency of rhCSF-1 is unknown.
LPS stimulates myelopoiesis in LPS-responsive mice, presumably by inducing the release of CSFs (15, 37) . In the present investigation, injection of LPS into BALB/c and C.D2 mice produced alterations in bone marrow and spleen cell numbers which resembled those observed in C3H/OuJ (Lpsn) mice after LPS injection (23) . Bone marrow hypocellularity appears to be the result of an exodus of mature polymorphonuclear neutrophils from bone marrow reserves (37 (23) . In contrast, the number of cells in peak II remained relatively stable over time in C.D2 mice. The emergence of a population of very large bone marrow cells (hatched area to the right of peak II) was noted in both strains, but this cell population appeared earlier (day 5 versus day 7) in BALB/c mice. The profiles are representative of two separate experiments.
LPS administration and suggests that both BALB/c and C.D2 mice react to the LPS injection in a typical LPSresponsive fashion (23) . In four separate experiments, LPS failed to induce an increase in bone marrow CFU-M or CFU-GM of either strain of mice. This is in contrast to a previous study from our laboratory in which femoral bone marrow stem cell colonies were found to increase in C3H/ OuJ mice treated with 25 p,g of the same lot of LPS (21 (10, 27, 39) . Alternatively, the elaboration of CSFs and other related cytokines by bone marrow stromal cells included in the pulverized bone-bone marrow cell preparation may have produced synergistic effects that increase myeloid stem cell proliferation (45) .
The only apparent difference observed in the response of BALB/c and C.D2 mice to LPS injection was the presence of an inhibitor in the CSF bioassay when serum from C.D2 mice was assayed (Fig. 1) (1, 27, 42) . Myelopoiesis is regulated by stimulatory and inhibitory cytokines released by accessory cells into the microenvironment of hemopoietic tissues (45) , and myeloproliferation is the net result of the opposing effects of these cytokines on myeloid progenitors (5, 27) . Recent (5, 27) . The dramatic increase in the number of large cells found in the bone marrow of BALB/c mice infected with S. typhimunium (Fig. 4 ) may indicate the presence of an expanded macrophage progenitor pool, because similar changes in cell sizing profiles noted in previous studies have correlated with proliferation of the macrophage progenitor pool (23) .
In vitro studies suggest that the effects of many myelopoietic inhibitory cytokines can be overcome by increasing the availability of CSFs to the stem cell (5, 27, 40) , and an attempt to augment in vivo host immunity to S. typhimurium by administering an exogenous CSF has been reported by Morrissey and Charrier (28) . Administration of rmuGM-CSF significantly prolonged the survival time of Ityr mice infected with S. typhimurium but did not benefit Ity' mice. Unfortunately, the effect of rmuGM-CSF on myeloid stem cell proliferation was not investigated in this study.
